Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Loses 41 Points. More details...
While an Influenza Pandemic Is On Everyone's Mind. More...
Doing More With Monoclonal Antibodies. More details...
CBT 200 Adds 27 Points. More details...
A List Of Players To Watch. More details...
The CBT 200 Drops 62 Points. More details...
CBT 200 Rises 39 Points. More details...
Novartis Strengthens Its Vaccine Position. More details...
Bush Proposes Avian Flu Plan. More details...
CBT Slips 11 Points. More details...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here